Screener
ClearPoint Neuro CLPT Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,330 | $1,256 |
| Accrued compensation | 2,977 | 4,360 |
| Other accrued liabilities | 2,125 | 2,786 |
| Operating lease liabilities, current portion | 234 | 694 |
| Contract liabilities, current portion | 1,814 | 1,669 |
| Total current liabilities | 9,480 | 10,765 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's accrued expenses?
- ClearPoint Neuro (CLPT) reported accrued expenses of $2.98M in Q1 2026.
- How has ClearPoint Neuro's accrued expenses changed year-over-year?
- ClearPoint Neuro's accrued expenses increased by 53.1% year-over-year, from $1.94M to $2.98M.
- What is the long-term trend for ClearPoint Neuro's accrued expenses?
- Over 5 years (2020 to 2025), ClearPoint Neuro's accrued expenses has grown at a 22.3% compound annual growth rate (CAGR), from $1.6M to $4.36M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about ClearPoint Neuro's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude